March 2026

UROLOGY

ROBOTIC RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE 2 SEMINOMA

Shilajit Kundu, MD, reviews the case of a young patient with early stage 2 metastatic seminoma presenting with isolated retroperitoneal lymph node disease. Dr. Kundu outlines the rationale for selecting robotic retroperitoneal lymph node dissection, and he offers practical insight by discussing patient selection, operative approach, perioperative outcomes and pathologic findings.
Shilajit Kundu, MD, Chief of Urologic Oncology, the Samar Kumar Kundu Professor of Urology and Professor of Urology at Northwestern Medicine 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like